Neutral
DarioHealth Corp. ( DRIO ) Reports Q2 Loss, Misses Revenue Estimates
DarioHealth (DRIO) delivered earnings and revenue surprises of -9.09% and -22.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?